Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The laboratory of Professor Vincenzo Cerundolo has won a CRUK Programme Grant for their work on development of vaccination strategies to enhance tumour specific immune responses.

Prof. Cerundolo said, 'We aim to gain a better understanding of the mechanisms which control the cell-cell interplay required for optimal activation of tumour-specific immune responses and to apply this knowledge to the development of better treatment of cancer patients.  In the next quinquennium we will study the role of invariant NKT cells to enhance immune responses against tumours in combination with the intense local damage caused by radiation and chemotherapy and in combination with immune checkpoint inhibitors. We will also study innate and adaptive immune responses activated by intravesical BCG injection in Bladder cancer patients. Understanding the mechanisms by which CD1 restricted T cells are activated upon triggering of sterile and non-sterile inflammatory pathways will provide important insights into anti cancer therapeutic opportunities.'



Similar stories

Annual WIMM fundraiser raises over £1000 for urology cancer research

Every year in early summer, a team of dedicated volunteers at the WIMM put together a series of fund-raising activities in aid of a local charity, which is often chosen because the beneficiary has links to staff and students at the Institute.

NIHR Research Professorship